South & Central America Veterinary Vaccines Market Size and Forecast (2021

Description

List of Tables

The South & Central America Veterinary Vaccines Market is projected to grow significantly, reaching an estimated US$ 357.1 million by 2031, up from US$ 294.0 million in 2024. This growth represents a compound annual growth rate (CAGR) of 2.8% from 2025 to 2031.

Executive Summary and Market Analysis

The veterinary vaccines market in South & Central America, which includes key countries like Brazil and Argentina, plays a crucial role in the global veterinary health landscape. The anticipated growth in this market is primarily driven by the rising demand for animal by-products such as meat, milk, and eggs, which necessitates effective disease prevention strategies in livestock. Additionally, continuous innovations in vaccine development aimed at enhancing effectiveness, safety, and delivery methods are expected to further stimulate market growth.

Government initiatives aimed at improving animal health, advancing vaccine research, and enhancing veterinary services are also contributing to the market's expansion. Brazil and Argentina, as major livestock producers, are experiencing advancements in both livestock and pet care markets, which are expected to bolster the demand for veterinary vaccines. Furthermore, other regions in South & Central America are increasingly focusing on modern veterinary healthcare practices, particularly in traditional livestock production.

Strategic Insights

Market Segmentation Analysis

The South & Central America Veterinary Vaccines Market can be segmented based on various criteria:

By Technology: The market is divided into Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others. In 2024, Live Attenuated Vaccines held the largest market share.
By Animal Type: The market is categorized into Companion Animals and Livestock & Poultry, with Livestock & Poultry dominating the market in 2024.
By Companion Animal: This segment includes Dogs, Cats, Horses, and Others, where Dogs accounted for the largest share in 2024.
By Livestock and Poultry: This includes Chicken, Cattle, and Others, with Chicken being the leading segment in 2024.
By Route of Administration: The market is segmented into Intramuscular, Subcutaneous, and Others, with Intramuscular administration holding the largest share in 2024.
By End User: This includes Veterinary Hospitals, Veterinary Clinics, and Others, where Veterinary Hospitals had the largest market share in 2024.

Market Outlook

The growth of manufacturing plants in the region presents a significant opportunity for the veterinary vaccines market. These facilities address critical issues such as production scalability, cost reduction, and improved accessibility of vaccines. The increasing demand for veterinary vaccines, driven by factors such as rising pet ownership, livestock husbandry needs, and international disease prevention initiatives, has led producers to invest in new manufacturing plants and upgrade existing ones.

For instance, in 2025, CDV Laboratorio announced plans to expand its operations in Pilar Industrial Park, Buenos Aires, projecting a 26% growth as part of its strategy to rank among the top 20 global veterinary vaccine laboratories. This expansion includes the construction of a third plant and significant investments in new facilities. Similarly, in 2024, Biogenesis Bago, a key player in the region, opened a new vaccine production facility in Campo Largo, Brazil, with an investment of approximately US$ 30 million, capable of producing over 10 million doses annually for both pet and farm animal vaccines.

These expansions not only enhance supply to meet global demand but also reduce production costs through economies of scale. Local manufacturing facilities facilitate quicker distribution and lessen reliance on imports, particularly in developing countries like Brazil and India. Government incentives promoting local production have further encouraged the establishment of regional manufacturing capabilities, leading to increased efficiency, innovation, and vaccine availability.

Country Insights

The South & Central America Veterinary Vaccines Market is further segmented by country, with Brazil, Argentina, and the Rest of South & Central America being the primary regions. Brazil held the largest market share in 2024.

Recent outbreaks of avian influenza A(H5) in Brazil, as reported by the Pan American Health Organization (PAHO), have heightened the focus on vaccination campaigns. The Brazilian government has implemented programs to control and eradicate foot-and-mouth disease (FMD), creating opportunities for market players to expand their operations in the country. For example, in July 2024, Biogenesis Bago inaugurated a new vaccine production facility in Campo Largo, Brazil, requiring a US$ 30 million investment, which will produce over 10 million doses of live attenuated virus vaccines annually, focusing initially on feline and canine vaccines.

Company Profiles

Key players in the South & Central America Veterinary Vaccines Market include Merck & Co Inc, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Zoetis Inc, Elanco Animal Health Inc, Virbac SA, Neogen Corp, Hester Biosciences Ltd, HIPRA SA, and Biovac LTD. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.

Product Code: TIPRE00041793

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

4. Veterinary Vaccines Market Landscape

4.2 PEST Analysis

5. South & Central America Veterinary Vaccines Market - Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:

6. Veterinary Vaccines Market - South & Central America Market Analysis

6.1 South & Central America Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 South & Central America Veterinary Vaccines Market Forecast and Analysis

7. South & Central America Veterinary Vaccines Market Revenue Analysis - by Technology

7.1 Live Attenuated Vaccines
- 7.1.1 Overview
- 7.1.2 Live Attenuated Vaccines: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated Vaccines
- 7.2.1 Overview
- 7.2.2 Inactivated Vaccines: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Recombinant Vaccines
- 7.3.1 Overview
- 7.3.2 Recombinant Vaccines: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Toxoid Vaccines
- 7.4.1 Overview
- 7.4.2 Toxoid Vaccines: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

8. South & Central America Veterinary Vaccines Market Revenue Analysis - by Animal Type

8.1 Companion
- 8.1.1 Overview
- 8.1.2 Companion: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Livestock and Poultry
- 8.2.1 Overview
- 8.2.2 Livestock and Poultry: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9. South & Central America Veterinary Vaccines Market Revenue Analysis - by Companion

9.1 Dogs
- 9.1.1 Overview
- 9.1.2 Dogs: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Cat
- 9.2.1 Overview
- 9.2.2 Cat: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Horses
- 9.3.1 Overview
- 9.3.2 Horses: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

10. South & Central America Veterinary Vaccines Market Revenue Analysis - by Livestock And Poultry

10.1 Chicken
- 10.1.1 Overview
- 10.1.2 Chicken: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Cattle
- 10.2.1 Overview
- 10.2.2 Cattle: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
- 10.3.1 Overview
- 10.3.2 Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

11. South & Central America Veterinary Vaccines Market Revenue Analysis - by Route Of Administration

11.1 Intramuscular
- 11.1.1 Overview
- 11.1.2 Intramuscular: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Subcutaneous
- 11.2.1 Overview
- 11.2.2 Subcutaneous: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 Others
- 11.3.1 Overview
- 11.3.2 Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

12. South & Central America Veterinary Vaccines Market Revenue Analysis - by End User

12.1 Veterinary Hospitals
- 12.1.1 Overview
- 12.1.2 Veterinary Hospitals: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Veterinary Clinics
- 12.2.1 Overview
- 12.2.2 Veterinary Clinics: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
- 12.3.1 Overview
- 12.3.2 Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

13. South & Central America Veterinary Vaccines Market - Country Analysis

13.1 South & Central America
- 13.1.1 South & Central America Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
  - 13.1.1.1 South & Central America Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
  - 13.1.2.2 Brazil: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.1.2.2.1 Brazil: South & Central America Veterinary Vaccines Market Share - by Technology
    - 13.1.2.2.2 Brazil: South & Central America Veterinary Vaccines Market Share - by Animal Type
    - 13.1.2.2.3 Brazil: South & Central America Veterinary Vaccines Market Share - by Companion
    - 13.1.2.2.4 Brazil: South & Central America Veterinary Vaccines Market Share - by Livestock And Poultry
    - 13.1.2.2.5 Brazil: South & Central America Veterinary Vaccines Market Share - by Route Of Administration
    - 13.1.2.2.6 Brazil: South & Central America Veterinary Vaccines Market Share - by End User
  - 13.2.3.3 Argentina: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.2.3.3.1 Argentina: South & Central America Veterinary Vaccines Market Share - by Technology
    - 13.2.3.3.2 Argentina: South & Central America Veterinary Vaccines Market Share - by Animal Type
    - 13.2.3.3.3 Argentina: South & Central America Veterinary Vaccines Market Share - by Companion
    - 13.2.3.3.4 Argentina: South & Central America Veterinary Vaccines Market Share - by Livestock And Poultry
    - 13.2.3.3.5 Argentina: South & Central America Veterinary Vaccines Market Share - by Route Of Administration
    - 13.2.3.3.6 Argentina: South & Central America Veterinary Vaccines Market Share - by End User
  - 13.3.4.4 Rest of South & Central America: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.3.4.4.1 Rest of South & Central America: South & Central America Veterinary Vaccines Market Share - by Technology
    - 13.3.4.4.2 Rest of South & Central America: South & Central America Veterinary Vaccines Market Share - by Animal Type
    - 13.3.4.4.3 Rest of South & Central America: South & Central America Veterinary Vaccines Market Share - by Companion
    - 13.3.4.4.4 Rest of South & Central America: South & Central America Veterinary Vaccines Market Share - by Livestock And Poultry
    - 13.3.4.4.5 Rest of South & Central America: South & Central America Veterinary Vaccines Market Share - by Route Of Administration
    - 13.3.4.4.6 Rest of South & Central America: South & Central America Veterinary Vaccines Market Share - by End User

15 Industry Landscape

15.1 Overview
15.2 New Product Development
15.3 Merger and Acquisition
15.4 Other Strategic Developments

16 COMPANY PROFILES

16.1 Merck & Co Inc
- 16.1.1 Key Facts
- 16.1.2 Business Description
- 16.1.3 Products and Services
- 16.1.4 Financial Overview
- 16.1.5 SWOT Analysis
- 16.1.6 Key Developments
16.2 Boehringer Ingelheim International GmbH
- 16.2.1 Key Facts
- 16.2.2 Business Description
- 16.2.3 Products and Services
- 16.2.4 Financial Overview
- 16.2.5 SWOT Analysis
- 16.2.6 Key Developments
16.3 Ceva Sante Animale
- 16.3.1 Key Facts
- 16.3.2 Business Description
- 16.3.3 Products and Services
- 16.3.4 Financial Overview
- 16.3.5 SWOT Analysis
- 16.3.6 Key Developments
16.4 Zoetis Inc
- 16.4.1 Key Facts
- 16.4.2 Business Description
- 16.4.3 Products and Services
- 16.4.4 Financial Overview
- 16.4.5 SWOT Analysis
- 16.4.6 Key Developments
16.5 Elanco Animal Health Inc
- 16.5.1 Key Facts
- 16.5.2 Business Description
- 16.5.3 Products and Services
- 16.5.4 Financial Overview
- 16.5.5 SWOT Analysis
- 16.5.6 Key Developments
16.6 Virbac SA
- 16.6.1 Key Facts
- 16.6.2 Business Description
- 16.6.3 Products and Services
- 16.6.4 Financial Overview
- 16.6.5 SWOT Analysis
- 16.6.6 Key Developments
16.7 Neogen Corp
- 16.7.1 Key Facts
- 16.7.2 Business Description
- 16.7.3 Products and Services
- 16.7.4 Financial Overview
- 16.7.5 SWOT Analysis
- 16.7.6 Key Developments
16.8 Hester Biosciences Ltd
- 16.8.1 Key Facts
- 16.8.2 Business Description
- 16.8.3 Products and Services
- 16.8.4 Financial Overview
- 16.8.5 SWOT Analysis
- 16.8.6 Key Developments
16.9 HIPRA SA
- 16.9.1 Key Facts
- 16.9.2 Business Description
- 16.9.3 Products and Services
- 16.9.4 Financial Overview
- 16.9.5 SWOT Analysis
- 16.9.6 Key Developments
16.10 Biovac LTD
- 16.10.1 Key Facts
- 16.10.2 Business Description
- 16.10.3 Products and Services
- 16.10.4 Financial Overview
- 16.10.5 SWOT Analysis
- 16.10.6 Key Developments

17. Appendix

17.1 About The Insight Partners